{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:33:10Z","timestamp":1786984390027,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:00:00Z","timestamp":1725667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:00:00Z","timestamp":1725667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-024-03825-7","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T07:02:20Z","timestamp":1725692540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Rescue therapy of early neurological deterioration in lacunar stroke"],"prefix":"10.1186","volume":"24","author":[{"given":"Soo-Hyun","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonguk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy W.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Kwon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joung-Ho","family":"Rha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,7]]},"reference":[{"key":"3825_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12883-014-0201-4","volume":"14","author":"BH Helleberg","year":"2014","unstructured":"Helleberg BH, Ellekj\u00e6r H, Rohweder G, Indredavik B. Mechanisms, predictors and clinical impact of early neurological deterioration: the protocol of the Trondheim early neurological deterioration study. BMC Neurol. 2014;14:201.","journal-title":"BMC Neurol"},{"key":"3825_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.5853\/jos.2020.01466","volume":"23","author":"DS Gwak","year":"2021","unstructured":"Gwak DS, Kwon JA, Shim DH, Kim YW, Hwang YH. Perfusion and diffusion variables predict early neurological deterioration in minor stroke and large vessel occlusion. J Stroke. 2021;23:61\u20138.","journal-title":"J Stroke"},{"key":"3825_CR3","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.3346\/jkms.2020.35.e325","volume":"35","author":"SH Park","year":"2020","unstructured":"Park SH, Kim TJ, Jeong HB, Ko SB. Lack of association between low cumulative dose of hydroxyethyl starch and acute kidney injury in patients with acute ischemic stroke. J Korean Med Sci. 2020;35:e325.","journal-title":"J Korean Med Sci"},{"key":"3825_CR4","doi-asserted-by":"publisher","first-page":"20610","DOI":"10.1038\/s41598-021-99920-7","volume":"11","author":"SH Kim","year":"2021","unstructured":"Kim SH, Jeon ET, Yu S, Oh K, Kim CK, Song TJ, et al. Interpretable machine learning for early neurological deterioration prediction in atrial fibrillation-related stroke. Sci Rep. 2021;11:20610.","journal-title":"Sci Rep"},{"key":"3825_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.5853\/jos.2016.00073","volume":"18","author":"JE Siegler","year":"2016","unstructured":"Siegler JE, Samai A, Semmes E, Martin-Schild S. Early neurologic deterioration after stroke depends on vascular territory and stroke etiology. J Stroke. 2016;18:203\u201310.","journal-title":"J Stroke"},{"key":"3825_CR6","doi-asserted-by":"publisher","first-page":"105885","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105885","volume":"30","author":"M Zhang","year":"2021","unstructured":"Zhang M, Zhu W, Ma Y, Huang K, Huang S, Chen Q, et al. Early neurological deterioration and hypoperfusion volume ratio on arterial spin labeling in patients with Acute ischemic stroke. J Stroke Cerebrovasc Dis. 2021;30:105885.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"3825_CR7","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/01.STR.29.4.743","volume":"29","author":"FT Aichner","year":"1998","unstructured":"Aichner FT, Fazekas F, Brainin M, P\u00f6lz W, Mamoli B, Zeiler K. Hypervolemic hemodilution in acute ischemic stroke: the Multicenter Austrian Hemodilution Stroke Trial (MAHST). Stroke. 1998;29:743\u20139.","journal-title":"Stroke"},{"key":"3825_CR8","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1001\/archsurg.139.5.552","volume":"139","author":"ME Barron","year":"2004","unstructured":"Barron ME, Wilkes MM, Navickis RJ. A systematic review of the comparative safety of colloids. Arch Surg. 2004;139:552\u201363.","journal-title":"Arch Surg"},{"key":"3825_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000077819","volume":"33","author":"R Woessner","year":"2003","unstructured":"Woessner R, Grauer MT, Dieterich HJ, Bepperling F, Baus D, Kahles T, et al. Influence of a long-term, high-dose volume therapy with 6% hydroxyethyl starch 130\/0.4 or crystalloid solution on hemodynamics, rheology and hemostasis in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study. Pathophysiol Haemost Thromb. 2003;33:121\u20136.","journal-title":"Pathophysiol Haemost Thromb"},{"key":"3825_CR10","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1056\/NEJMoa1209759","volume":"367","author":"JA Myburgh","year":"2012","unstructured":"Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901\u201311.","journal-title":"N Engl J Med"},{"key":"3825_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1056\/NEJMoa1204242","volume":"367","author":"A Perner","year":"2012","unstructured":"Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, \u00c5neman A, et al. Hydroxyethyl starch 130\/0.42 versus Ringer\u2019s acetate in severe sepsis. N Engl J Med. 2012;367:124\u201334.","journal-title":"N Engl J Med"},{"key":"3825_CR12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.5853\/jos.2019.00437","volume":"21","author":"MH Lee","year":"2019","unstructured":"Lee MH, Kim JG, Jeon SB, Kang DW, Kwon SU, Kim JS. Pharmacologically induced hypertension therapy for acute stroke patients. J Stroke. 2019;21:228\u201330.","journal-title":"J Stroke"},{"key":"3825_CR13","doi-asserted-by":"publisher","first-page":"e1955","DOI":"10.1212\/WNL.0000000000008520","volume":"93","author":"OY Bang","year":"2019","unstructured":"Bang OY, Chung JW, Kim SK, Kim SJ, Lee MJ, Hwang J, et al. Therapeutic-induced hypertension in patients with noncardioembolic acute stroke. Neurology. 2019;93:e1955\u201363.","journal-title":"Neurology"},{"key":"3825_CR14","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1161\/01.STR.0000131549.20581.ba","volume":"35","author":"MP LaMonte","year":"2004","unstructured":"LaMonte MP, Nash ML, Wang DZ, Woolfenden AR, Schultz J, Hursting MJ, et al. Argatroban anticoagulation in patients with acute ischemic stroke (ARGIS-1): a randomized, placebo-controlled safety study. Stroke. 2004;35:1677\u201382.","journal-title":"Stroke"},{"key":"3825_CR15","doi-asserted-by":"publisher","first-page":"107602962090413","DOI":"10.1177\/1076029620904131","volume":"26","author":"LS Zhou","year":"2020","unstructured":"Zhou LS, Li XQ, Zhou ZH, Chen HS. Effect of Argatroban Combined with Dual Antiplatelet Therapy on early neurological deterioration in Acute minor posterior circulation ischemic stroke. Clin Appl Thromb Hemost. 2020;26:1076029620904131.","journal-title":"Clin Appl Thromb Hemost"},{"key":"3825_CR16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1186\/s12883-021-02435-x","volume":"21","author":"PF Wang","year":"2021","unstructured":"Wang PF, Sun ZR, Yu JC, Geng N, Liu LY, Zhu LN, et al. Early argatroban and antiplatelet combination therapy in acute non-lacunar single subcortical infarct associated with mild intracranial atherosclerosis. BMC Neurol. 2021;21:440.","journal-title":"BMC Neurol"},{"key":"3825_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000512813","volume":"84","author":"P Huang","year":"2021","unstructured":"Huang P, He XY, Xu M. Effect of Argatroban Injection on Clinical Efficacy in patients with Acute Cerebral infarction: preliminary findings. Eur Neurol. 2021;84:38\u201342.","journal-title":"Eur Neurol"},{"key":"3825_CR18","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","volume":"333","author":"National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","year":"1995","unstructured":"National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581\u20137.","journal-title":"N Engl J Med"},{"key":"3825_CR19","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1161\/01.STR.32.5.1154","volume":"32","author":"J Serena","year":"2001","unstructured":"Serena J, Leira R, Castillo J, Pumar JM, Castellanos M, D\u00e1valos A. Neurological deterioration in acute lacunar infarctions: the role of excitatory and inhibitory neurotransmitters. Stroke. 2001;32:1154\u2013561.","journal-title":"Stroke"},{"key":"3825_CR20","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/ene.14159","volume":"27","author":"A Berberich","year":"2020","unstructured":"Berberich A, Schneider C, Herweh C, Hielscher T, Reiff T, Bendszus M, et al. Risk factors associated with progressive lacunar strokes and benefit from dual antiplatelet therapy. Eur J Neurol. 2020;27:817\u201324.","journal-title":"Eur J Neurol"},{"key":"3825_CR21","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/j.1468-1331.2008.02310.x","volume":"15","author":"KS Hong","year":"2008","unstructured":"Hong KS, Kang DW, Koo JS, Yu KH, Han MK, Cho YJ, et al. Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke. Eur J Neurol. 2008;15:1324\u201331.","journal-title":"Eur J Neurol"},{"key":"3825_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1001\/archneur.62.3.393","volume":"62","author":"C Weimar","year":"2005","unstructured":"Weimar C, Mieck T, Buchthal J, Ehrenfeld CE, Schmid E, Diener HC, et al. Neurologic worsening during the acute phase of ischemic stroke. Arch Neurol. 2005;62:393\u20137.","journal-title":"Arch Neurol"},{"key":"3825_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/ijs.12129","volume":"8","author":"SC Johnston","year":"2013","unstructured":"Johnston SC, Easton JD, Farrant M, Barsan W, Battenhouse H, Conwit R, et al. Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design. Int J Stroke. 2013;8:479\u201383.","journal-title":"Int J Stroke"},{"key":"3825_CR24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3988\/jcn.2007.3.4.187","volume":"3","author":"HJ Kim","year":"2007","unstructured":"Kim HJ, Kang DW. Induced hypertensive therapy in an acute ischemic stroke patient with early neurological deterioration. J Clin Neurol. 2007;3:187\u201391.","journal-title":"J Clin Neurol"},{"key":"3825_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1096\/fasebj.1.3.2887477","volume":"1","author":"JA Bevan","year":"1987","unstructured":"Bevan JA, Duckworth J, Laher I, Oriowo MA, McPherson GA, Bevan RD. Sympathetic control of cerebral arteries: specialization in receptor type, reserve, affinity, and distribution. FASEB J. 1987;1:193\u20138.","journal-title":"FASEB J"},{"key":"3825_CR26","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1161\/STROKEAHA.117.016720","volume":"48","author":"AD Barreto","year":"2017","unstructured":"Barreto AD, Ford GA, Shen L, Pedroza C, Tyson J, Cai C, et al. Randomized, Multicenter Trial of ARTSS-2 (Argatroban with recombinant tissue plasminogen activator for Acute Stroke). Stroke. 2017;48:1608\u201316.","journal-title":"Stroke"},{"key":"3825_CR27","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.08.036","volume":"27","author":"K Berekashvili","year":"2018","unstructured":"Berekashvili K, Soomro J, Shen L, Misra V, Chen PR, Blackburn S, et al. Safety and feasibility of Argatroban, recombinant tissue plasminogen activator, and intra-arterial therapy in Stroke (ARTSS-IA Study). J Stroke Cerebrovasc Dis. 2018;27:3647\u201351.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"8 Pt 2","key":"3825_CR28","doi-asserted-by":"publisher","first-page":"757","DOI":"10.7326\/0003-4819-127-8_Part_2-199710151-00064","volume":"127","author":"DB Rubin","year":"1997","unstructured":"Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127(8 Pt 2):757\u201363.","journal-title":"Ann Intern Med"},{"key":"3825_CR29","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/jcbfm.2013.77","volume":"33","author":"BC Campbell","year":"2013","unstructured":"Campbell BC, Christensen S, Tress BM, Churilov L, Desmond PM, Parsons MW, et al. Failure of collateral blood flow is associated with infarct growth in ischemic stroke. J Cereb Blood Flow Metab. 2013;33:1168\u201372.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3825_CR30","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1161\/STROKEAHA.113.004072","volume":"45","author":"DS Liebeskind","year":"2014","unstructured":"Liebeskind DS, Tomsick TA, Foster LD, Yeatts SD, Carrozzella J, Demchuk AM, et al. Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial. Stroke. 2014;45:759\u201364.","journal-title":"Stroke"},{"key":"3825_CR31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/jon.12314","volume":"26","author":"HS Nam","year":"2016","unstructured":"Nam HS, Scalzo F, Leng X, Ip HL, Lee HS, Fan F, et al. Hemodynamic impact of systolic blood pressure and hematocrit calculated by Computational Fluid Dynamics in patients with intracranial atherosclerosis. J Neuroimaging. 2016;26:331\u20138.","journal-title":"J Neuroimaging"},{"key":"3825_CR32","doi-asserted-by":"publisher","first-page":"222","DOI":"10.5853\/jos.2016.01739","volume":"19","author":"B Jiang","year":"2017","unstructured":"Jiang B, Churilov L, Kanesan L, Dowling R, Mitchell P, Dong Q, et al. Blood pressure may be Associated with arterial collateralization in anterior circulation ischemic stroke before Acute Reperfusion Therapy. J Stroke. 2017;19:222\u20138.","journal-title":"J Stroke"},{"key":"3825_CR33","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1385\/NCC:1:3:287","volume":"1","author":"JC Rose","year":"2004","unstructured":"Rose JC, Mayer SA. Optimizing blood pressure in neurological emergencies. Neurocrit Care. 2004;1:287\u201399.","journal-title":"Neurocrit Care"},{"key":"3825_CR34","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1475-097X.2011.01040.x","volume":"31","author":"S Ogoh","year":"2011","unstructured":"Ogoh S, Sato K, Fisher JP, Seifert T, Overgaard M, Secher NH. The effect of phenylephrine on arterial and venous cerebral blood flow in healthy subjects. Clin Physiol Funct Imaging. 2011;31:445\u201351.","journal-title":"Clin Physiol Funct Imaging"},{"key":"3825_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/0006-8993(76)90356-5","volume":"115","author":"L Edvinsson","year":"1976","unstructured":"Edvinsson L, Owman C, Sj\u00f6berg NO. Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study. Brain Res. 1976;115:377\u201393.","journal-title":"Brain Res"},{"key":"3825_CR36","doi-asserted-by":"publisher","first-page":"e443","DOI":"10.1161\/STROKEAHA.108.532465","volume":"40","author":"JA Alawneh","year":"2009","unstructured":"Alawneh JA, Moustafa RR, Baron JC. Hemodynamic factors and perfusion abnormalities in early neurological deterioration. Stroke. 2009;40:e443\u201350.","journal-title":"Stroke"},{"key":"3825_CR37","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1161\/STROKEAHA.113.004488","volume":"45","author":"P Lyden","year":"2014","unstructured":"Lyden P, Pereira B, Chen B, Zhao L, Lamb J, Lei IF, et al. Direct thrombin inhibitor argatroban reduces stroke damage in 2 different models. Stroke. 2014;45:896\u20139.","journal-title":"Stroke"},{"key":"3825_CR38","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with Acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of Acute ischemic stroke: a Guideline for Healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2019;50:e344\u2013418.","journal-title":"Stroke"},{"key":"3825_CR39","first-page":"CD000024","volume":"2015","author":"PA Sandercock","year":"2015","unstructured":"Sandercock PA, Counsell C, Kane EJ. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev. 2015;2015:CD000024.","journal-title":"Cochrane Database Syst Rev"},{"key":"3825_CR40","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1474-4422(13)70079-6","volume":"12","author":"WN Whiteley","year":"2013","unstructured":"Whiteley WN, Adams HP Jr, Bath PM, Berge E, Sandset PM, Dennis M, et al. Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials. Lancet Neurol. 2013;12:539\u201345.","journal-title":"Lancet Neurol"},{"key":"3825_CR41","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1161\/01.STR.28.11.2133","volume":"28","author":"G Rordorf","year":"1997","unstructured":"Rordorf G, Cramer SC, Efird JT, Schwamm LH, Buonanno F, Koroshetz WJ. Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. Stroke. 1997;28:2133\u20138.","journal-title":"Stroke"},{"key":"3825_CR42","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1212\/WNL.56.9.1210","volume":"56","author":"G Rordorf","year":"2001","unstructured":"Rordorf G, Koroshetz WJ, Ezzeddine MA, Segal AZ, Buonanno FS. A pilot study of drug-induced hypertension for treatment of acute stroke. Neurology. 2001;56:1210\u20133.","journal-title":"Neurology"},{"key":"3825_CR43","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1159\/000071122","volume":"16","author":"AE Hillis","year":"2003","unstructured":"Hillis AE, Ulatowski JA, Barker PB, Torbey M, Ziai W, Beauchamp NJ, et al. A pilot randomized trial of induced blood pressure elevation: effects on function and focal perfusion in acute and subacute stroke. Cerebrovasc Dis. 2003;16:236\u201346.","journal-title":"Cerebrovasc Dis"},{"issue":"1\u20132","key":"3825_CR44","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jns.2011.06.009","volume":"308","author":"TS Lim","year":"2011","unstructured":"Lim TS, Hong JM, Lee JS, Shin DH, Choi JY, Huh K. Induced-hypertension in progressing lacunar infarction. J Neurol Sci. 2011;308(1\u20132):72\u20136.","journal-title":"J Neurol Sci"},{"key":"3825_CR45","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jns.2017.04.008","volume":"377","author":"MJ Kang","year":"2017","unstructured":"Kang MJ, Yang JW, Lee YB, Park KH, Park HM, Shin DJ, et al. The role of phenylephrine in patients with small deep subcortical infarct and progressive weakness. J Neurol Sci. 2017;377:107\u201311.","journal-title":"J Neurol Sci"},{"key":"3825_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1385\/NCC:4:1:003","volume":"4","author":"MA Koenig","year":"2006","unstructured":"Koenig MA, Geocadin RG, de Grouchy M, Glasgow J, Vimal S, Restrepo L, et al. Safety of induced hypertension therapy in patients with acute ischemic stroke. Neurocrit Care. 2006;4:3\u20137.","journal-title":"Neurocrit Care"},{"key":"3825_CR47","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1001\/archinte.163.15.1849","volume":"163","author":"BE Lewis","year":"2003","unstructured":"Lewis BE, Wallis DE, Leya F, Hursting MJ, Kelton JG, et al. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia. Arch Intern Med. 2003;163:1849\u201356.","journal-title":"Arch Intern Med"},{"key":"3825_CR48","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1161\/01.STR.0000014584.17714.2E","volume":"33","author":"S Schwarz","year":"2002","unstructured":"Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of induced hypertension on intracranial pressure and flow velocities of the middle cerebral arteries in patients with large hemispheric stroke. Stroke. 2002;33:998\u20131004.","journal-title":"Stroke"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03825-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-024-03825-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03825-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T11:25:34Z","timestamp":1725967534000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-024-03825-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,7]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3825"],"URL":"https:\/\/doi.org\/10.1186\/s12883-024-03825-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,7]]},"assertion":[{"value":"7 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the institutional review board of Inha University Hospital, Incheon, Korea (IRB number: 2019-06-024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"329"}}